07/29/2013 - 1:41pm

Drug maker Pfizer is planning to split its commercial division into three business lines that will separate its branded and generic products, the company said Monday.

07/29/2013 - 12:31pm

Dr. Reddy's Labs has launched a generic drug used to treat Alzheimer's disease, the company said.

07/29/2013 - 9:35am

Actavis hopes to become the first to market a generic drug for treating chronic pain, the company said.

07/29/2013 - 8:50am

U.S.-based drug maker Perrigo Co. will buy Ireland's Elan Corp. for $8.6 billion, the companies said.

07/26/2013 - 1:30pm

A federal court has ruled in favor of generic drug maker Sandoz in a case involving a drug for multiple sclerosis, Sandoz said.

07/26/2013 - 11:25am

Anda VP purchasing Marc Falkin wrote in an email to coworkers and friends that he would begin working for Actavis as VP marketing, pricing and contract operations for the Parsippany, N.J.-based drug maker's generics business.

07/26/2013 - 11:19am

A new track-and-trace bill that the Senate is expected to consider would institute a nationwide "track-and-trace" system in place of patchwork state laws with the aim of securing the pharmaceutical supply chain.

07/25/2013 - 9:04am

Mylan and Orion Corp. have settled a patent-infringement suit over a drug used to treat Parkinson's disease.

07/24/2013 - 3:33pm

The Food and Drug Administration has granted the manufacturer of Plan B One-Step exclusive marketing rights for three years, according to published reports.